Mäentausta O, Peltoketo H, Isomaa V, Jouppila P, Vihko R
Department of Clinical Chemistry, University of Oulu, Finland.
J Steroid Biochem. 1990 Aug 28;36(6):673-80. doi: 10.1016/0022-4731(90)90187-w.
Human placental 17 beta-hydroxysteroid dehydrogenase (17-HSD) was purified to apparent homogeneity using ammonium sulfate precipitation and chromatography on Red-Agarose and DEAE-Sepharose columns. Electrophoresis on polyacrylamide gels under denaturing conditions and using silver staining showed a single protein with an apparent molecular weight of 37,800. Antibodies to the purified protein were raised in rabbits and were found by immunoblotting to be specific to 17-HSD. A sensitive radioimmunoassay was established using 125I-labeled 17-HSD as a tracer, an appropriate dilution of the antibody, and a kaolin-coupled double antibody for separating the antibody-bound and free fractions. The detection limit of the assay was approximately 150 pg/tube (1.5 micrograms/l). The cytosol fraction (105,000 g) of term placental tissue contained approximately 0.7 mg of 17-HSD per gram of protein, and the concentrations of 17-HSD measured by immunoassay and enzymatic activity proved to be strictly parallel in different partly purified placental preparations. The supernatants from centrifugations of human endometrial homogenates at 800 g and 105,000 g (after detergent treatment) displayed cross-reactivity with the antibody. The mean concentration of the cross-reacting substance in the radioimmunoassay was 14.1 micrograms/g protein (range 2-62.3) in specimens taken on different days in the cycle. These concentrations showed a significant correlation with the 17-HSD activities measured in the endometrial specimens (r = 0.722, P less than 0.001, n = 21). Mean concentrations of substance were 8.3 micrograms/g protein in endometrial specimens taken during the follicular phase (days 4-12, n = 8) and 22.9 micrograms/g protein during the luteal phase (days 16-22, n = 6) were obtained using the radioimmunoassay. There was excellent parallelism between the competition curves for [125I]iodo-17-HSD with purified 17-HSD standards and placental and endometrial homogenate dilutions. These data strongly suggest that the substance measured in the endometrial specimens was 17-HSD.
采用硫酸铵沉淀以及在红琼脂糖和二乙氨基乙基琼脂糖柱上进行层析的方法,将人胎盘17β - 羟基类固醇脱氢酶(17 - HSD)纯化至表观均一。在变性条件下于聚丙烯酰胺凝胶上进行电泳并用银染法显示,有一条表观分子量为37,800的单一蛋白质条带。用纯化的蛋白质对家兔进行免疫,制备抗血清,通过免疫印迹法发现其对17 - HSD具有特异性。建立了一种灵敏的放射免疫测定法,使用125I标记的17 - HSD作为示踪剂、适当稀释的抗体以及高岭土偶联的双抗体来分离抗体结合部分和游离部分。该测定法的检测限约为150 pg/管(1.5 μg/L)。足月胎盘组织的胞质溶胶部分(105,000 g)每克蛋白质中约含0.7 mg的17 - HSD,在不同的部分纯化胎盘制剂中,通过免疫测定法和酶活性测定的17 - HSD浓度显示出严格的平行关系。人子宫内膜匀浆经800 g和105,000 g离心(去污剂处理后)得到的上清液与该抗体呈现交叉反应。在月经周期不同日子采集的标本中,放射免疫测定法测得的交叉反应物质的平均浓度为14.1 μg/g蛋白质(范围为2 - 62.3)。这些浓度与子宫内膜标本中测得的17 - HSD活性呈现显著相关性(r = 0.722,P < 0.001,n = 21)。使用放射免疫测定法,在卵泡期(第4 - 12天,n = 8)采集的子宫内膜标本中该物质的平均浓度为8.3 μg/g蛋白质,在黄体期(第16 - 22天,n = 6)为22.9 μg/g蛋白质。[125I]碘代 - 17 - HSD与纯化的17 - HSD标准品以及胎盘和子宫内膜匀浆稀释液的竞争曲线之间具有良好的平行关系。这些数据有力地表明,在子宫内膜标本中测得的物质就是17 - HSD。